Literature DB >> 29552180

SIRT6 inhibits colorectal cancer stem cell proliferation by targeting CDC25A.

Wenguang Liu1,2, Manwu Wu3, Hechun Du3, Xiaoliang Shi3, Tao Zhang3, Jie Li1.   

Abstract

Silent information regulator 6 (SIRT6) is broadly considered as a tumor suppressor due to its function in the suppression of oncogene expression. However, the role of SIRT6 in colorectal cancer stem cells (CSCs) remains uncharacterized. In the present study, it was demonstrated that SIRT6 expression was reduced in colorectal CSCs. Overexpression of SIRT6 in colorectal CSCs did not induce cell apoptosis. However, SIRT6 significantly inhibited cell proliferation, colony formation and induced G0/G1 phase arrest in colorectal CSCs. In addition, SIRT6 repressed the expression of cell division cycle 25A (CDC25A), an oncogenic phosphatase. Chromatin immunoprecipitation experiments indicated that SIRT6 directly bound to the CDC25A promoter and decreased the acetylation level of histone H3 lysine 9. Altogether, these data indicated that SIRT6 inhibits colorectal cancer stem cell proliferation by targeting CDC25A.

Entities:  

Keywords:  cancer stem cells; cell cycle; cell division cycle 25A; cell proliferation; silent information regulator 6

Year:  2018        PMID: 29552180      PMCID: PMC5840749          DOI: 10.3892/ol.2018.7989

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  26 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.

Authors:  Anastasia R Demidova; Mei Yee Aau; Li Zhuang; Qiang Yu
Journal:  J Biol Chem       Date:  2008-12-07       Impact factor: 5.157

3.  SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.

Authors:  Long-Kuan Ran; Yong Chen; Zhen-Zhen Zhang; Na-Na Tao; Ji-Hua Ren; Li Zhou; Hua Tang; Xiang Chen; Ke Chen; Wan-Yu Li; Ai-Long Huang; Juan Chen
Journal:  Clin Cancer Res       Date:  2016-02-09       Impact factor: 12.531

4.  Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.

Authors:  Yaron Pereg; Bob Y Liu; Karen M O'Rourke; Meredith Sagolla; Anwesha Dey; Laszlo Komuves; Dorothy M French; Vishva M Dixit
Journal:  Nat Cell Biol       Date:  2010-03-14       Impact factor: 28.824

5.  SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells.

Authors:  Michael Van Meter; Zhiyong Mao; Vera Gorbunova; Andrei Seluanov
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

6.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

7.  Altered expression of SIRT gene family in head and neck squamous cell carcinoma.

Authors:  Chi-Chih Lai; Pai-Mei Lin; Sheng-Fung Lin; Cheng-Hsien Hsu; Hsin-Ching Lin; Ming-Luen Hu; Cheng-Ming Hsu; Ming-Yu Yang
Journal:  Tumour Biol       Date:  2013-03-12

8.  SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b.

Authors:  Sita Kugel; Carlos Sebastián; Julien Fitamant; Kenneth N Ross; Supriya K Saha; Esha Jain; Adrianne Gladden; Kshitij S Arora; Yasutaka Kato; Miguel N Rivera; Sridhar Ramaswamy; Ruslan I Sadreyev; Alon Goren; Vikram Deshpande; Nabeel Bardeesy; Raul Mostoslavsky
Journal:  Cell       Date:  2016-05-12       Impact factor: 41.582

9.  CDC25 phosphatases as potential human oncogenes.

Authors:  K Galaktionov; A K Lee; J Eckstein; G Draetta; J Meckler; M Loda; D Beach
Journal:  Science       Date:  1995-09-15       Impact factor: 47.728

10.  MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer.

Authors:  Umadevi Thirumurthi; Jia Shen; Weiya Xia; Adam M LaBaff; Yongkun Wei; Chia-Wei Li; Wei-Chao Chang; Chung-Hsuan Chen; Hui-Kuan Lin; Dihua Yu; Mien-Chie Hung
Journal:  Sci Signal       Date:  2014-07-29       Impact factor: 8.192

View more
  16 in total

Review 1.  The sirtuin 6: An overture in skin cancer.

Authors:  Liz M Garcia-Peterson; Glorimar Guzmán-Pérez; Cassandre R Krier; Nihal Ahmad
Journal:  Exp Dermatol       Date:  2019-12-29       Impact factor: 3.960

Review 2.  Association of sirtuins (SIRT1-7) with lung and intestinal diseases.

Authors:  Yuhan Chen; Di Zhou; Yuan Feng; Bingxin Li; Yong Cui; Gang Chen; Ning Li
Journal:  Mol Cell Biochem       Date:  2022-05-20       Impact factor: 3.396

3.  SIRT6 promotes ferroptosis and attenuates glycolysis in pancreatic cancer through regulation of the NF-κB pathway.

Authors:  Shuangxi Gong; Lixin Xiong; Zhen Luo; Qinghua Yin; Ming Huang; Yang Zhou; Jian Li
Journal:  Exp Ther Med       Date:  2022-06-08       Impact factor: 2.751

4.  Partial Depletion of Peripheral M1 Macrophages Reverses Motor Deficits in MPTP-Treated Mouse by Suppressing Neuroinflammation and Dopaminergic Neurodegeneration.

Authors:  Aijuan Yan; Yu Zhang; Jingya Lin; Lu Song; Xijin Wang; Zhenguo Liu
Journal:  Front Aging Neurosci       Date:  2018-06-05       Impact factor: 5.750

5.  SIRT6 overexpression induces apoptosis of nasopharyngeal carcinoma by inhibiting NF-κB signaling.

Authors:  Lei Ouyang; Liang Yi; Jingkun Li; Shijiang Yi; Shisheng Li; Peng Liu; Xinming Yang
Journal:  Onco Targets Ther       Date:  2018-11-01       Impact factor: 4.147

6.  The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.

Authors:  Joana Sales-Dias; Gabriela Silva; Márcia Lamy; Andreia Ferreira; Ana Barbas
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

7.  Circular RNA circ_0007142 Facilitates Colorectal Cancer Progression by Modulating CDC25A Expression via miR-122-5p.

Authors:  Wenzhe Yin; Jun Xu; Chao Li; Xiankui Dai; Tong Wu; Jifeng Wen
Journal:  Onco Targets Ther       Date:  2020-05-01       Impact factor: 4.147

8.  MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer.

Authors:  Jia-Lin Shang; Shao-Bo Ning; Ying-Yi Chen; Tian-Xiang Chen; Jian Zhang
Journal:  Acta Pharmacol Sin       Date:  2020-06-15       Impact factor: 6.150

9.  Pharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells.

Authors:  Sara Iachettini; Daniela Trisciuoglio; Dante Rotili; Alessia Lucidi; Erica Salvati; Pasquale Zizza; Luca Di Leo; Donatella Del Bufalo; Maria Rosa Ciriolo; Carlo Leonetti; Clemens Steegborn; Antonello Mai; Angela Rizzo; Annamaria Biroccio
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

10.  Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D3 in colorectal cancer.

Authors:  Jialin Shang; Zhehui Zhu; Yingyi Chen; Jinglue Song; Yuji Huang; Kun Song; Jie Zhong; Xinyuan Xu; Jiacheng Wei; Chengxiang Wang; Long Cui; Chen-Ying Liu; Jian Zhang
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.